Role of Adiponectin in Coronary Heart Disease Risk

Supplemental Digital Content is available in the text.

[1]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[2]  Christian Gieger,et al.  New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.

[3]  E. Ding,et al.  Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. , 2009, JAMA.

[4]  F. Potier,et al.  What is known , 2003 .

[5]  Christian Gieger,et al.  Common Variants at 10 Genomic Loci Influence Hemoglobin A1C Levels via Glycemic and Nonglycemic Pathways , 2010, Diabetes.

[6]  Eric J Tchetgen Tchetgen,et al.  Methodological Challenges in Mendelian Randomization , 2014, Epidemiology.

[7]  A. Butterworth,et al.  Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.

[8]  Brian A Ference,et al.  Clinical Effect of Naturally Random Allocation to Lower Systolic Blood Pressure Beginning Before the Development of Hypertension , 2014, Hypertension.

[9]  Stephen Burgess,et al.  Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants , 2016, Epidemiology.

[10]  Hynek Pikhart,et al.  HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials , 2015, The Lancet.

[11]  Tamara S. Roman,et al.  New genetic loci link adipose and insulin biology to body fat distribution , 2014, Nature.

[12]  Nuala A Sheehan,et al.  Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome , 2015, Statistics in medicine.

[13]  Ross M. Fraser,et al.  Genetic studies of body mass index yield new insights for obesity biology , 2015, Nature.

[14]  P. Visscher,et al.  Calculating statistical power in Mendelian randomization studies. , 2013, International journal of epidemiology.

[15]  S. Kihara,et al.  Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001, Circulation.

[16]  Mark I. McCarthy,et al.  Mendelian Randomization Studies Do Not Support a Causal Role for Reduced Circulating Adiponectin Levels in Insulin Resistance and Type 2 Diabetes , 2013, Diabetes.

[17]  Alessandro Pontillo,et al.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.

[18]  L. Kappelle,et al.  Adiponectin and incident coronary heart disease and stroke. A systematic review and meta‐analysis of prospective studies , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[19]  P. Scherer,et al.  Adiponectin: Just Along for the Ride? , 2016, Circulation research.

[20]  J. Danesh,et al.  Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data , 2011, BMJ : British Medical Journal.

[21]  J. Danesh,et al.  Large-scale association analysis identifies new risk loci for coronary artery disease , 2013 .

[22]  T. Saruta,et al.  Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. , 2004, The Journal of clinical endocrinology and metabolism.

[23]  P. Whincup,et al.  High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[24]  Eugene Kim,et al.  Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis. , 2013, International journal of epidemiology.

[25]  D. Lawlor,et al.  Clustered Environments and Randomized Genes: A Fundamental Distinction between Conventional and Genetic Epidemiology , 2007, PLoS medicine.

[26]  Wei Li,et al.  Serum total adiponectin level and the risk of cardiovascular disease in general population: a meta-analysis of 17 prospective studies. , 2013, Atherosclerosis.

[27]  Bengt Sennblad,et al.  Sex-Specific Effects of Adiponectin on Carotid Intima-Media Thickness and Incident Cardiovascular Disease , 2015, Journal of the American Heart Association.

[28]  M. Sowers,et al.  Adipocytokine and ghrelin levels in relation to cardiovascular disease risk factors in women at midlife: longitudinal associations , 2008, International Journal of Obesity.

[29]  P. Scherer,et al.  Adiponectin: mechanistic insights and clinical implications , 2012, Diabetologia.

[30]  N. Timpson,et al.  Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors , 2015, European Journal of Epidemiology.

[31]  Karen L. Mohlke,et al.  Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals , 2012, PLoS genetics.

[32]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[33]  G. Davey Smith,et al.  Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.

[34]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[35]  B. Zhang,et al.  Serum total adiponectin level and risk of cardiovascular disease in Han Chinese populations: a meta‐analysis of 17 case–control studies , 2012, Clinical endocrinology.

[36]  D. Absher,et al.  Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-Wide Association Meta-analysis Involving More Than 22 000 Cases and 60 000 Controls , 2010, Circulation. Cardiovascular genetics.

[37]  E. Ingelsson,et al.  Evidence of a Causal Relationship Between Adiponectin Levels and Insulin Sensitivity , 2013, Diabetes.

[38]  P. Froguel,et al.  Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.

[39]  F. Dudbridge,et al.  Re: "Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects". , 2015, American journal of epidemiology.

[40]  S. Thompson,et al.  Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects , 2015, American journal of epidemiology.

[41]  Jie Cao,et al.  Adiponectin Levels and Risk of Coronary Heart Disease: A Meta-analysis of Prospective Studies , 2013, The American journal of the medical sciences.

[42]  S. Yusuf,et al.  Causal Relationship between Adiponectin and Metabolic Traits: A Mendelian Randomization Study in a Multiethnic Population , 2013, PloS one.

[43]  Mark Woodward,et al.  Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies , 2012 .

[44]  Florian Kronenberg,et al.  The shared allelic architecture of adiponectin levels and coronary artery disease. , 2013, Atherosclerosis.

[45]  N. Mehta.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. , 2011, Circulation. Cardiovascular genetics.

[46]  Tom R. Gaunt,et al.  HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials , 2015, The Lancet.